EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Is gonadotropin-releasing hormone agonist usage really leading to thyroid dysfunction?

Nafiye Yilmaz, Necati Hancerliogullari, Mustafa Kara, Yaprak Engin-Ustun

Interventional Medicine and Applied Science · 16.09.2020 · 11 (3) · 136-138

DOI: 10.1556/1646.10.2018.32 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Interventional Medicine and Applied Science, erschienen am 16.09.2020. Verfasst von Nafiye Yilmaz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Zekai Tahir Burak Women's Health Education and Research Hospital, Ankara, Turkey. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Gonadotropin-releasing hormone agonist (GnRHa) could influence the levels of sex hormones and thyroid hormones. The aim of this study was to investigate the effect of GnRHa on thyroid function. Materials and methods The data of the patients were collected from the registrations of July 2014–October 2014. A total of 41 women who underwent one-time IVF cyclus were evaluated in this cross-sectional study. The patients were categorized into two groups according to the serum T 3 , T 4 , and TSH levels before and 2 weeks’ after the administration of GnRHa.

Results

Mean basal TSH and mean TSH levels on hCG day were 1.98 ± 0.77 and 1.75 ± 0.70, respectively. The difference between the two groups was statistically significant ( p < 0.05). GnRHa did not lead to statistically significant difference on serum-free T 3 and T 4 levels.

Conclusions

In conclusion, our results demonstrate that GnRHa led to a decrease on serum TSH level. Serum-free T 3 and T 4 levels were remained unchanged and this might be due to early measurement of the hormone levels (just 2 weeks later from GnRHa administration).

Schlagwörter

Stichwörter der Autor:innen

GnRHaIVF–ICSIgonadotropininfertilitythyroid hormones

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Zekai Tahir Burak Women's Health Education and Research Hospital, Ankara, Turkey.
  • Department of Obstetrics and Gynecology, School of Medicine, Bozok University, Yozgat, Turkey.

Zitieren

APA

Yilmaz, N., Hancerliogullari, N., Kara, M., & Engin-Ustun, Y. (2020). Is gonadotropin-releasing hormone agonist usage really leading to thyroid dysfunction?. Interventional Medicine and Applied Science, 11(3), 136-138. https://doi.org/10.1556/1646.10.2018.32

Vancouver

Yilmaz N, Hancerliogullari N, Kara M, Engin-Ustun Y. Is gonadotropin-releasing hormone agonist usage really leading to thyroid dysfunction?. Interventional Medicine and Applied Science. 2020;11(3):136-138. doi:10.1556/1646.10.2018.32

BibTeX
@article{Yilmaz2020,
  author = {Yilmaz, Nafiye and Hancerliogullari, Necati and Kara, Mustafa and Engin-Ustun, Yaprak},
  title = {Is gonadotropin-releasing hormone agonist usage really leading to thyroid dysfunction?},
  journal = {Interventional Medicine and Applied Science},
  year = {2020},
  volume = {11},
  number = {3},
  pages = {136--138},
  doi = {10.1556/1646.10.2018.32}
}
Kostenlos starten →